https://www.selleckchem.com/products/OSI-906.html
177, 0.946), all-cause death (RR 0.441; 95% CI 0.263, 0.739), MI (RR 0.554; 95% CI 0.414, 0.741) and stent thrombosis (RR 0.587; 95% CI 0.348, 0.988) than the latter patient group. The risk of stroke was not significantly different between patients receiving the alternatives and those receiving clopidogrel (RR 0.605; 95% CI 0.257, 1.425). Major and minor bleeding risk was not significantly different between patients treated with alternatives and clopidogrel (RR 1.019; 95% CI 0.827, 1.260 and RR 1.235; 95% CI 0.581, 2.628, respectively).
Like
Comment
Share
